Cargando…

Dyskeratosis congenita and the DNA damage response

Dyskeratosis congenita (DC) is a heterogeneous bone marrow failure disorder with known mutations in components of telomerase and telomere shelterin. Recent work in a mouse model with a dyskerin mutation has implicated an increased DNA damage response as part of the cellular pathology, while mouse mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirwan, Michael, Beswick, Richard, Walne, Amanda J, Hossain, Upal, Casimir, Colin, Vulliamy, Tom, Dokal, Inderjeet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328754/
https://www.ncbi.nlm.nih.gov/pubmed/21477209
http://dx.doi.org/10.1111/j.1365-2141.2011.08679.x
_version_ 1782229769167831040
author Kirwan, Michael
Beswick, Richard
Walne, Amanda J
Hossain, Upal
Casimir, Colin
Vulliamy, Tom
Dokal, Inderjeet
author_facet Kirwan, Michael
Beswick, Richard
Walne, Amanda J
Hossain, Upal
Casimir, Colin
Vulliamy, Tom
Dokal, Inderjeet
author_sort Kirwan, Michael
collection PubMed
description Dyskeratosis congenita (DC) is a heterogeneous bone marrow failure disorder with known mutations in components of telomerase and telomere shelterin. Recent work in a mouse model with a dyskerin mutation has implicated an increased DNA damage response as part of the cellular pathology, while mouse models with Terc and Tert mutations displayed a normal response. To clarify how these contradictory results might apply to DC pathology in humans, we studied the cellular phenotype in primary cells from DC patients of several genetic subtypes, focussing on T lymphocytes to remain close to the haematopoietic system. We observed novel cell cycle abnormalities in conjunction with impaired growth and an increase in apoptosis. Using flow cytometry and confocal microscopy we examined induction of the DNA damage proteins γ-H2AX and 53BP1 and the cell cycle protein TP53 (p53). We found an increase in damage foci at telomeres in lymphocytes and an increase in the basal level of DNA damage in fibroblasts, but crucially no increased response to DNA damaging agents in either cell type. As the response to induced DNA damage was normal and levels of global DNA damage were inconsistent between cell types, DNA damage may contribute differently to the pathology in different tissues.
format Online
Article
Text
id pubmed-3328754
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-33287542012-04-18 Dyskeratosis congenita and the DNA damage response Kirwan, Michael Beswick, Richard Walne, Amanda J Hossain, Upal Casimir, Colin Vulliamy, Tom Dokal, Inderjeet Br J Haematol Paediatric Dyskeratosis congenita (DC) is a heterogeneous bone marrow failure disorder with known mutations in components of telomerase and telomere shelterin. Recent work in a mouse model with a dyskerin mutation has implicated an increased DNA damage response as part of the cellular pathology, while mouse models with Terc and Tert mutations displayed a normal response. To clarify how these contradictory results might apply to DC pathology in humans, we studied the cellular phenotype in primary cells from DC patients of several genetic subtypes, focussing on T lymphocytes to remain close to the haematopoietic system. We observed novel cell cycle abnormalities in conjunction with impaired growth and an increase in apoptosis. Using flow cytometry and confocal microscopy we examined induction of the DNA damage proteins γ-H2AX and 53BP1 and the cell cycle protein TP53 (p53). We found an increase in damage foci at telomeres in lymphocytes and an increase in the basal level of DNA damage in fibroblasts, but crucially no increased response to DNA damaging agents in either cell type. As the response to induced DNA damage was normal and levels of global DNA damage were inconsistent between cell types, DNA damage may contribute differently to the pathology in different tissues. Blackwell Publishing Ltd 2011-06 /pmc/articles/PMC3328754/ /pubmed/21477209 http://dx.doi.org/10.1111/j.1365-2141.2011.08679.x Text en © 2011 Blackwell Publishing Ltd http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
spellingShingle Paediatric
Kirwan, Michael
Beswick, Richard
Walne, Amanda J
Hossain, Upal
Casimir, Colin
Vulliamy, Tom
Dokal, Inderjeet
Dyskeratosis congenita and the DNA damage response
title Dyskeratosis congenita and the DNA damage response
title_full Dyskeratosis congenita and the DNA damage response
title_fullStr Dyskeratosis congenita and the DNA damage response
title_full_unstemmed Dyskeratosis congenita and the DNA damage response
title_short Dyskeratosis congenita and the DNA damage response
title_sort dyskeratosis congenita and the dna damage response
topic Paediatric
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328754/
https://www.ncbi.nlm.nih.gov/pubmed/21477209
http://dx.doi.org/10.1111/j.1365-2141.2011.08679.x
work_keys_str_mv AT kirwanmichael dyskeratosiscongenitaandthednadamageresponse
AT beswickrichard dyskeratosiscongenitaandthednadamageresponse
AT walneamandaj dyskeratosiscongenitaandthednadamageresponse
AT hossainupal dyskeratosiscongenitaandthednadamageresponse
AT casimircolin dyskeratosiscongenitaandthednadamageresponse
AT vulliamytom dyskeratosiscongenitaandthednadamageresponse
AT dokalinderjeet dyskeratosiscongenitaandthednadamageresponse